简体
简体中文
繁體中文

VanEck Vectors Video Gaming & eSports ETF ESPO

等待开盘 02-20 09:30:00 美东时间

93.35

-0.041

-0.04%

华盛通华盛通
立即下载
  • 最 高93.41
  • 今 开92.93
  • 成交量 1.87万股
  • 最 低 92.93
  • 昨 收 93.3907
  • 总市值 2.85亿
  • 52周最高 121.697
  • 市盈率 --
  • 换手率 0.61%
  • 52周最低 76.621
  • 委 比 14.94%
  • 总股本 305.00万
  • 历史最高 121.697
  • 量 比 0.83
  • 振 幅 0.51%
  • 历史最低 20.8301
  • 每 手 1
  • 风险率 9.97%

个股概要

财务分析

公司资料

相关新闻

分红派息

  • 分时图
  • 日k
  • 周k
  • 月k

相关新闻

更多
  • BRIEF-Aprea Therapeutics Announces Additional Positive Clinical Activity For Wee1 Inhibitor, APR-1051

    BRIEF-Aprea Therapeutics Announces Additional Positive Clinical Activity For Wee1 Inhibitor, APR-1051 Feb 18 (Reuters) - Aprea Therapeutics Inc APRE.O : APREA THERAPEUTICS ANNOUNCES ADDITIONAL POSITIVE CLINICAL ACTIVITY FOR WEE1 INHIBITOR, APR-1051, INCLUDING SECOND PARTIAL RESPONSE IN ONGOING ACESO

    02-18 22:06

  • FACTBOX-Elon Musk's Grok faces global scrutiny for sexualised AI deepfakes

    FACTBOX-Elon Musk's Grok faces global scrutiny for sexualised AI deepfakes Updates with Ireland's investigation paragraph 10, Spain's probe paragraph 11 Feb 17 (Reuters) - Governments and regulators around the world are cracking down on sexually explicit content generated by Elon Musk's xAI chatbot

    02-17 17:11

  • BRIEF-Celon Pharma Says FDA Deems Phase III Study Concept For CPL'36 Treatment Reasonable

    BRIEF-Celon Pharma Says FDA Deems Phase III Study Concept For CPL'36 Treatment Reasonable Feb 13 (Reuters) - Celon Pharma SA CLNP.WA : ANNOUNCES COMPLETION OF ANALYSIS OF WRITTEN RESPONSES FROM FDA REGARDING CPL'36 FOR PARKINSON'S DISEASE-INDUCED DYSKINESIA (PD-LID) FDA DEEMS PROPOSED PHASE III STUD

    02-14 00:18

  • BRIEF-NY State Public Service Commission Approves NYSERDA Offshore Wind Implementation Plan

    BRIEF-NY State Public Service Commission Approves NYSERDA Offshore Wind Implementation Plan Feb 12 (Reuters) - NEW YORK STATE PUBLIC SERVICE COMMISSION: SAYS THE NEW YORK STATE PUBLIC SERVICE COMMISSION (COMMISSION) TODAY APPROVED THE NEW YORK STATE ENERGY RESEARCH AND DEVELOPMENT AUTHORITY'S (NYSER

    02-13 03:02

  • Benitec Biopharma Q2 net loss widens

    Benitec Biopharma Q2 net loss widens Overview Gene therapy firm's Q2 net loss widened to $11.8 mln Company's R&D expenses in Q2 were $5.8 mln, consistent with last year Company plans FDA meeting mid-2026 for BB-301 pivotal study design Outlook Company plans FDA meeting to finalize BB-301 pivotal stu

    02-12 21:37

  • GLOBAL MARKETS-Stocks near record highs after bullish US jobs data; dollar sags

    GLOBAL MARKETS-Stocks near record highs after bullish US jobs data; dollar sags Updates prices Stocks near record highs after US jobs data Dollar rally peters out Focus now on US inflation data on Friday Yen gains on investor bets on fiscally responsible Takaichi By Amanda Cooper LONDON, Feb 12 (Reu

    02-12 21:02

  • BRIEF-GNK Holdings & Marcus Lemonis Reiterate $1.10 All-Cash Proposal For Bark

    BRIEF-GNK Holdings & Marcus Lemonis Reiterate $1.10 All-Cash Proposal For Bark Feb 11 (Reuters) - GNK Holdings : GNK HOLDINGS AND MARCUS LEMONIS REITERATE SUPERIOR $1.10 ALL-CASH PROPOSAL FOR BARK AND DEMAND RESPONSE FROM SPECIAL COMMITTEE Source text: ID:nGNX25vDG8 Further company coverage: BARK.N

    02-11 23:34

  • BRIEF-Marinemax Inc Responds To Donerail's Public Letter To Shareholders

    BRIEF-Marinemax Inc Responds To Donerail's Public Letter To Shareholders Feb 10 (Reuters) - MarineMax Inc HZO.N : MARINEMAX INC - RESPONDS TO DONERAIL'S PUBLIC LETTER TO SHAREHOLDERS MARINEMAX INC - BOARD IS UNANIMOUS IN ITS SUPPORT FOR CEO BRETT MCGILL MARINEMAX INC - COMMITTED TO ONGOING BOARD REF

    02-10 23:27

  • BRIEF-REGENXBIO Announces Regulatory Update on RGX-121 BLA for MPS II

    BRIEF-REGENXBIO Announces Regulatory Update on RGX-121 BLA for MPS II Feb 9 (Reuters) - Regenxbio Inc RGNX.O : REGENXBIO ANNOUNCES REGULATORY UPDATE ON RGX-121 BLA FOR MPS II REGENXBIO INC - FDA ISSUES COMPLETE RESPONSE LETTER FOR RGX-121 REGENXBIO INC - PLANS TO RESUBMIT BLA FOR RGX-121 REGENXBIO I

    02-10 05:53

  • BRIEF-Air Canada Suspending Cuba Service In Response To Aviation Fuel Shortage

    BRIEF-Air Canada Suspending Cuba Service In Response To Aviation Fuel Shortage Feb 9 (Reuters) - Air Canada AC.TO : AIR CANADA SUSPENDING CUBA SERVICE IN RESPONSE TO AVIATION FUEL SHORTAGE AIR CANADA - FLIGHTS TO VARADERO AND CAYO COCO SUSPENDED UNTIL MAY 1 AIR CANADA: WILL OPERATE EMPTY FLIGHTS SOU

    02-10 01:30